Avicenna Journal of Medical Biotechnology
Published by Avicenna Research Institute
ISSN : 2008-2835 eISSN : 2008-4625
Abbreviation : Avicenna J. Med. Biotechnol.
Aims & Scope
Avicenna Journal of Medical Biotechnology (AJMB) provides a medium for the publication of both full-length articles and short communications on all aspects of medical biotechnology.
The Journal will accept papers ranging from genetic or molecular biological aspects to those covering biochemical, chemical or bioprocess engineering aspects, provided that in each case the material is directly relevant to medical biotechnology systems.
The following areas are covered by the Journal: Medical Biotechnology, New Products, Nucleic Acids, Gene therapy, Molecular Biology, Nanobiotechnology, Bioinformatics, Biodiagnostics, Biochemistry, Biochemical Engineering, Bioprocess Engineering, Transgenic therapeutics, Biotherapeutics, Industrial Processes, Clinical trial reports, Bioethics and Biopharmaceuticals.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.330 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
Journal Rank
Year | Value |
---|---|
2024 | 15727 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 149 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Chemical Engineering, Engineering and Immunology and Microbiology, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Comparison of Antifungal Properties of Gold, Silver, and Selenium Nanoparticles Against Amphotericin B-Resistant Candida glabrata Clinical Isolates
Citation: 11
Authors: Ensieh, Hossein, Kamyab, Azam, Amirali, Reza, Mahyar, Yasaman, Sayna
-
CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
Citation: 10
Authors: Saeedeh, Hashem, Samaneh, Mona, Saber, Milad, Zahra
-
β-sitosterol Mediated Silver Nanoparticles Induce Cytotoxicity in Human Colon Cancer HT-29 Cells
Citation: 8
Authors: Palaniappan, Devaraj, Shanmugam, Jayaraman
-
The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds
Citation: 6
Authors: Samira, Negar, Niloofar, Tahereh
-
Designing a Strategy for pH Control to Improve CHO Cell Productivity in Bioreactor
Citation: 6
Authors: Zohreh, Mahdi, Paria, Rasoul, Razieh, Aram, Shayan
-
GC/MS Analysis and Phyto-synthesis of Silver Nanoparticles Using Amygdalus spinosissima Extract: Antibacterial, Antioxidant Effects, Anticancer and Apoptotic Effects
Citation: 6
Authors: Azadeh, Seyed Mohammad Mahdi, Amir
-
Evaluation of Metastasis Suppressor Genes Expression and In Vitro Anti-Cancer Effects of Zinc Oxide Nanoparticles in Human Breast Cancer Cell Lines MCF-7 and T47D
Citation: 5
Authors: Seyed Ataollah, Faryad, Sorayya, Fatemeh, Fahimeh
-
The Inhibitory Effect of Thioridazine on adeB Efflux Pump Gene Expression in Multidrug-Resistant Acinetobacter baumannii Isolates Using Real Time PCR
Citation: 5
Authors: Fereshteh, Bahman, Saba, Mehdi, Narges, Farzad, Seyed Sajjad
-
New Biomarkers in Early Diagnosis of Acute Kidney Injury in Children
Citation: 5
Authors: Behnaz, Mastaneh
-
The Impact of Nrf2 Silencing on Nrf2-PD-L1 Axis to Overcome Oxaliplatin Resistance and Migration in Colon Cancer Cells
Citation: 5
Authors: Zahra, Abbas, Behzad, Vahid, Milad, Behzad, Nasser